| | | | | | | | Register for the 2022 World Congress on Pain | The IASP World Congress on Pain, 19 – 23 September, in Toronto, is the largest global gathering of pain professionals. World Congress brings together more than 7,000 scientists, clinicians, and healthcare providers from around the world and across pain disciplines. Register by 29 April to receive the early bird discount. Learn more and register. | | | | | | | | Apply for a Developing Countries Project Grant by 8 April | Developing Countries Project Grants provide up to $10,000 to help improve pain education and practice in developing countries. These Grants can facilitate projects such as combining practical instruction with the latest research, developing written teaching materials, and creating online learning programs. Application deadline: 8 April. | | | | | | | | | Register for the 5 April Global Year Webinar | | | | IASP will host the first 2022 Global Year webinar, Success Stories: Translating Insights from Genetic Analyses in Painful Small Fiber Neuropathy into Pharmacological Practice – Lacosamide. This webinar will feature: • Karin Faber, MD, PhD, Maastricht University, the Netherlands • Heike Rittner, MD, University Hospital of Wuerzburg, Germany The two will discuss Lacosamide, an FDA-approved treatment for epilepsy, and how insights from the genetic analyses of pain patients led to its investigation for use in the management of neuropathic pain. Learn more and register. | | ![]() | | | | | | | | | | Registration Opens Wednesday, 30 March for Pre-World Congress Events | | Pre-World Congress Events provide attendees opportunities for interactive hands-on workshops and deep-dive refresher courses, making the most of your World Congress experience. | - Refresher Courses are full-day events on Monday, 19 September and provide attendees opportunities to learn the latest information on an array of topics that are critical to the study of pain.
- Hands-On Workshops are innovative sessions on Monday, 19 September and provide attendees with opportunities to practice the latest methods and gain hands-on experience to better understand and apply the techniques learned in these workshops and labs to their working practice.
| ![]() | | | | | | | SIG Symposia Registration Opening Soon | Special Interest Group Symposia will provide attendees with an in-depth exploration of their specific discipline, including recent discoveries and the latest research developments in their area of interest. Select SIGs will hold their half-day or full-day symposia Monday, 19 September. | ![]() | | | | World Congress Speakers Lecturers Announced | | | | Award Lectures - Luda Diatchenko, MD, PhD, McGill University, Canada, Ronald Melzack Award Lecture
- Patrik Ernfors, PhD, Karolinska Institutet, Sweden, William D. Willis, Jr. Memorial Award Lecture
- Michael Nicholas, PhD, Royal North Shore Hospital, Australia, John D. Loeser Award Lecture
- Rolf-Detlef Treede, MD, University of Heidelberg, Germany, John J. Bonica Award Lecture
| | Plenary Lectures - Isaac Chiu, PhD, Harvard Medical School, USA
- Thomas Graven-Nielsen, DMSc, PhD, Aalborg University, Denmark
- Carmen Green, MD, City University of New York School of Medicine, USA
- Ed Keogh, PhD, University of Bath, United Kingdom
- Michaela Kress, MD, PhD, Innsbruck Medical University, Austria
- Rebecca Pillai Riddell, MA, PhD, Professor, York University, Canada
- Maree Smith, PhD, The University of Queensland, Australia
- Irina Vetter, PhD, The University of Queensland, Australia
- Tor Wager, PhD, Dartmouth University, USA
| | | | | | | | | ![]() | | Register and Book Your Housing to Attend World Congress | Register and book your housing to attend World Congress. World Congress will bring together pain professionals to enhance their professional skills and knowledge about the latest innovations in pain research. | | | | | Register for the 5 April Global Year Webinar | | | | | | | | | | | | | | | | | New evidence shows that the cytokine oncostatin M (OSM) potentiates itch signaling in neurons and is a key mediator of inflammatory itch disease in humans. Blocking OSM signaling could be an exciting new treatment for chronic itch. | | | ![]() | | | | | | | In this episode, The Pain Beat brought together guests from a variety of career stages to share their experiences conducting pain and pain-related research during the COVID-19 pandemic. Their discussion highlighted unique and shared experiences, how research priorities and strategies shifted in response to the pandemic, as well as ways in which colleagues found and offered support. | | | | ![]() | | | | | | Each week, PRF editors curate their weekly selection of papers from the basic science, translational and clinical pain research literature, and highlight a few papers of particular interest. These Editors’ Picks can be found here. Two Editors’ Picks from this past month of great value to the PRF community are: | | Tavares-Ferreira D, Shiers S, Ray PR, Wangzhou A, Jeevakumar V, Sankaranarayanan I, Cervantes AM, Reese JC, Chamessian A, Copits BA, Dougherty PM, Gereau RW, Burton MD, Dussor G, Price TJ Sci Transl Med. 2022. | | ![]() | | | | Trask S, Mogil JS, Helmstetter FJ, Stucky CL, Sadler KE Elife. 2022. | ![]() | | | | | | |
_(8)_2176797.png)
_2160081.png)
